Which statement about methylphenidate is true?

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

Which statement about methylphenidate is true?

Explanation:
The key idea here is how stimulant medications interact with monoamine oxidase inhibitors. Methylphenidate boosts levels of norepinephrine and dopamine in the brain, while MAO inhibitors block the breakdown of these monoamines. Together, they can cause a dangerous surge of norepinephrine, leading to a hypertensive crisis with dangerously high blood pressure, rapid heart rate, and other serious cardiovascular effects. Because of this risk, coadministration is typically contraindicated or requires careful medical management and a washout period. The other statements aren’t correct because there are known interactions with various medications (not just this one), caffeine is not an absolute contraindication though it can amplify stimulant effects, and there isn’t evidence that methylphenidate reliably reduces anticoagulant effects.

The key idea here is how stimulant medications interact with monoamine oxidase inhibitors. Methylphenidate boosts levels of norepinephrine and dopamine in the brain, while MAO inhibitors block the breakdown of these monoamines. Together, they can cause a dangerous surge of norepinephrine, leading to a hypertensive crisis with dangerously high blood pressure, rapid heart rate, and other serious cardiovascular effects. Because of this risk, coadministration is typically contraindicated or requires careful medical management and a washout period.

The other statements aren’t correct because there are known interactions with various medications (not just this one), caffeine is not an absolute contraindication though it can amplify stimulant effects, and there isn’t evidence that methylphenidate reliably reduces anticoagulant effects.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy